AI-first platform transforms recruitment delays into instant enrollments by matching, engaging and enrolling patients in ...

The reliance of the pharmaceutical industry on data is fairly high for planning clinical trials, managing resources, and bringing new drugs to market. Yet one of its biggest challenges remains the ...

Local startup QuEra attracts major investment from NVIDIA, highlighting the city's growing influence in the global ...

The global digital biomarkers market is set to witness a growth rate of 20% in the next 5 years. Rising prevalence of chronic ...

A targeted drug that extends the life of people with lung cancer has been approved for use on the NHS. Durvalumab, also known ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Prota Therapeutics Pty Ltd ("Prota"), a clinical-stage biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced ...

Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed its ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...